Researchers analyzing data from 140,000 people have found that expanded diagnostic criteria, rather than actual increases in prevalence, explain the steep rise in autism and ADHD diagnoses over recent decades. The study reveals that relaxed thresholds for diagnosis account for most of the documented increase in cases.
The work demonstrates that when researchers apply historical diagnostic standards to modern populations, diagnosis rates remain relatively stable. However, when contemporary criteria are used, rates climb sharply. This pattern indicates that diagnostic expansion, not a true surge in these conditions, drives the observed trend.
The findings carry an important caveat. The researchers emphasize that broadened criteria do not necessarily mean too many people receive diagnoses. Instead, the expanded definitions capture individuals who previously went undiagnosed despite experiencing genuine difficulties. Many people with autism and ADHD struggled for years without recognition because earlier, narrower criteria excluded them from diagnosis.
Widening diagnostic criteria has enabled clinicians to identify people across a broader spectrum of presentation. Autism now encompasses greater variation in how traits manifest. ADHD diagnostic thresholds have similarly shifted to recognize more subtle presentations and different symptom patterns. These changes reflect improved understanding of how both conditions present in diverse populations, including girls and women historically underdiagnosed under stricter criteria.
The study's implication cuts both ways. The dramatic rise in diagnoses reflects genuine clinical progress in recognizing previously invisible cases. Simultaneously, it shows that much of the apparent "epidemic" stems from definitional changes rather than environmental or genetic factors causing new disease emergence.
This distinction matters for public health planning and resource allocation. Understanding that diagnosis numbers reflect better case-finding rather than true prevalence increases helps policymakers target support where it's needed. However, it also raises questions about whether current criteria are appropriately calibrated and whether diagnostic services can meet growing demand from newly identified populations.
The research appears in a peer-reviewed publication
